Rare Disease Trial, Recruiting NCT06435195 Sponsor: Peking Union Medical College Hospital Condition: Rare Disease
Back to Rare Disease

Rare Disease Trial, Recruiting

NCT06435195
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with a rare disease affecting the sellar region (an area at the base of the brain near the pituitary gland), such as pituitary tumors, craniopharyngiomas, Rathke's cleft cysts, germ cell tumors in that area, cavernous sinus syndrome, or similar conditions
  • You have detailed medical records available, including your symptoms, the treatments you received, and records of how you were monitored over time

Who may not be able to join:

  • Your medical records are incomplete, particularly if important imaging results (such as MRI or CT scans) are missing
  • You have a separate, unrelated brain or nervous system condition, such as a severe traumatic brain injury
  • Your original diagnosis related to the sellar region was later changed or found to be incorrect during follow-up care

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yong Yao, MD, Department of Neurosurgery, Peking Union Medical College Hospital

Phone: +8669152530

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 January 2024
Est. completion
1 September 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Remission

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov